These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18617550)

  • 1. Comment on: Use of parenteral methotrexate significantly reduces the need for biological therapy.
    Thornton C; Ong V; Ward J; Kennedy N; Steuer A
    Rheumatology (Oxford); 2008 Sep; 47(9):1438; author reply 1438. PubMed ID: 18617550
    [No Abstract]   [Full Text] [Related]  

  • 2. Limitations of the study of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: comment on the article by Braun et al.
    Raghu P; Grover PS; Kumar A
    Arthritis Rheum; 2008 Jul; 58(7):2209; author reply 2209-10. PubMed ID: 18576338
    [No Abstract]   [Full Text] [Related]  

  • 3. Subcutaneous methotrexate is well tolerated and superior to oral methotrexate in the treatment of rheumatoid arthritis.
    Hameed B; Jones H
    Int J Rheum Dis; 2010 Oct; 13(4):e83-4. PubMed ID: 21199461
    [No Abstract]   [Full Text] [Related]  

  • 4. Subtherapeutic dosing of methotrexate in rheumatoid arthritis trials.
    Parker CT; Mewshaw E; Dennis GJ
    J Am Osteopath Assoc; 2004 Jan; 104(1):7-8. PubMed ID: 14992316
    [No Abstract]   [Full Text] [Related]  

  • 5. [Subcutaneous self-administration of methotrexate in rheumatoid arthritis].
    Huisman AM; Schouten JP; van Paassen HC; Wouters JM; Jacobs JW
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1564-5. PubMed ID: 8765767
    [No Abstract]   [Full Text] [Related]  

  • 6. Parenteral methotrexate should be given before biological therapy.
    Griffin AJ; Erkeller-Yuksel F
    Rheumatology (Oxford); 2004 May; 43(5):678; author reply 678-9. PubMed ID: 15103040
    [No Abstract]   [Full Text] [Related]  

  • 7. Self-injection of gold and methotrexate.
    Arthur V; Jubb R; Homer D
    J Rheumatol; 2001 Jan; 28(1):212. PubMed ID: 11196528
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioavailability of higher dose MTX comparing oral and subcutaneous administration in patients with RA.
    Rau R
    J Rheumatol; 2005 Jul; 32(7):1412; author reply 1412-3. PubMed ID: 15996092
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of parenteral methotrexate significantly reduces the need for biological therapy.
    Bharadwaj A; Agrawal S; Batley M; Hammond A
    Rheumatology (Oxford); 2008 Feb; 47(2):222. PubMed ID: 18056146
    [No Abstract]   [Full Text] [Related]  

  • 10. Folic acid and folinic acid supplementation during low-dose methotrexate therapy for rheumatoid arthritis: comment on the article by van Ede et al.
    Morgan SL; Baggott JE; Alarcón GS; Koopman WJ
    Arthritis Rheum; 2002 May; 46(5):1413-4. PubMed ID: 12115259
    [No Abstract]   [Full Text] [Related]  

  • 11. [For parenteral gold therapy in rheumatoid arthritis].
    Wassenberg S
    Dtsch Med Wochenschr; 2011 Aug; 136(33):1676. PubMed ID: 21833891
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methotrexate: mainstay of rheumatoid arthritis treatment].
    Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 2009; 153():A879. PubMed ID: 19785862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why subcutaneous methotrexate should be a prerequisite to biologic use in patients with rheumatoid arthritis.
    Koduri GM; Mukhtyar C
    Rheumatology (Oxford); 2019 Apr; 58(4):559-560. PubMed ID: 29672739
    [No Abstract]   [Full Text] [Related]  

  • 14. [The initial results of the Metex Study].
    Braun J
    Krankenpfl J; 2005; 43(7-10):246-7. PubMed ID: 16515316
    [No Abstract]   [Full Text] [Related]  

  • 15. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis.
    Wassenberg S; Rau R
    J Rheumatol; 2003 Aug; 30(8):1891; author reply 1891-2. PubMed ID: 12913889
    [No Abstract]   [Full Text] [Related]  

  • 16. In brief: otrexup--a single-use auto-injector formulation of methotrexate.
    Med Lett Drugs Ther; 2014 Mar; 56(1439):28. PubMed ID: 24691150
    [No Abstract]   [Full Text] [Related]  

  • 17. Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients?
    Pincus T; Sokka T
    Rheumatology (Oxford); 2006 May; 45(5):497-9. PubMed ID: 16537578
    [No Abstract]   [Full Text] [Related]  

  • 18. [Methotrexate therapy for rheumatism and collagen diseases].
    Osone Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Aug; 25(4):330-6. PubMed ID: 16646163
    [No Abstract]   [Full Text] [Related]  

  • 19. Herpes zoster encephalomyelitis in a patient with rheumatoid arthritis treated with low dose methotrexate.
    Golden HE
    J Rheumatol; 1997 Dec; 24(12):2487-8. PubMed ID: 9415667
    [No Abstract]   [Full Text] [Related]  

  • 20. Subcutaneous methotrexate to cut costs?
    Hassanzadeh R; Mangan C; France J; Bawa S
    J Rheumatol; 2012 Aug; 39(8):1764-5. PubMed ID: 22859538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.